 |
Previous Article | Next Article 
The Journal of Neuroscience, July 1, 2002, 22(13):5321-5327
Two Different Mechanisms of Disinhibition Produced by
GABAA Receptor Mutations Linked to Epilepsy in Humans
Matt T.
Bianchi1,
Luyan
Song2,
Helen
Zhang1, and
Robert L.
Macdonald2, 3, 4
1 Neuroscience Graduate Program, University of
Michigan, Ann Arbor, Michigan 48104-1687, and Departments of
2 Neurology, 3 Molecular Physiology and
Biophysics, and 4 Pharmacology, Vanderbilt University,
Nashville, Tennessee 37212
 |
ABSTRACT |
The first mutations of the GABAA receptor channel
linked to familial epilepsy in humans were reported recently (Baulac et al., 2001 ; Wallace et al., 2001 ). Preliminary functional analysis of
1 2 2 GABAA receptors expressed in
Xenopus oocytes suggested that the 2 subunit R43Q
mutation abolished current enhancement by the benzodiazepine, diazepam,
and that the 2 subunit K289M mutation decreased current amplitudes.
We used single-channel recording and concentration jump techniques
applied to outside out patches to evaluate the impact of these
mutations on GABAA receptor channel function of the highly
conserved rat ortholog subunits expressed in human embryonic kidney
cells. When coexpressed with 1 and 3 subunits, no differences
were observed between wild-type and mutant GABAA receptor
current activation rates or rates or extent of desensitization during
prolonged (400 msec) GABA application (1 mM). Although
deactivation after brief (5 msec) or prolonged (400 msec) GABA
application was unaltered by the R43Q mutation,
deactivation (a correlate of IPSC duration) was accelerated for the
K289M mutation. Faster deactivation was likely a consequence of altered
gating, because single-channel openings had shorter mean duration.
Interestingly, the R43Q mutation did not alter diazepam potentiation.
It did, however, substantially decrease current amplitude, which was
not caused by decreased single-channel conductance or open time,
suggesting reduced surface expression of functional receptors. The two
2 subunit mutations likely produce disinhibition and familial
epilepsy by distinct mechanisms, suggesting that maintenance of
neuronal inhibition depends not only on the peak amplitude of IPSCs,
but also on their time course.
Key words:
GABAA receptor; mutation; epilepsy; concentration-jump; benzodiazepine; deactivation
 |
INTRODUCTION |
GABAA
receptors mediate the majority of fast synaptic inhibition in the
brain. The heteropentameric receptor complex is comprised of subunits
drawn from at least seven families ( , , , , , , ),
although the majority of receptors are thought to be   and
  isoforms (McKernan and Whiting, 1996 ). Subunit composition has been shown to influence the pharmacology, kinetics, and subcellular localization of GABAA receptors (Macdonald and
Olsen, 1994 ; Sieghart, 1995 ). Pharmacological enhancement of GABAergic
inhibition has been used in the treatment of several clinical
disorders, including anxiety and epilepsy, and certain anesthetics
mediate their CNS actions at least in part through enhancement
of GABAA receptor function.
Two recent studies demonstrated for the first time a genetic linkage
between familial epilepsy syndromes and mutations in the 2 subunit
of the GABAA receptor. Wallace et al. (2001)
reported a missense mutation, R43Q (in the N terminal extracellular
domain of the 2 subunit), in affected individuals of a large family having both childhood absence epilepsy and febrile seizures.
Recordings from Xenopus oocytes injected with
1 2 2(R43Q) GABAA receptor subunits
suggested no differences in GABA EC50, current
amplitude, or apparent desensitization. However, the receptors were
insensitive to functional modulation by the benzodiazepine diazepam.
Although this raised the interesting possibility of an endogenous
ligand at the benzodiazepine recognition site, that interpretation
depends on the exclusion of any other functional consequences of the
mutation. Baulac et al. (2001) reported that a family with
an epilepsy disorder similar to generalized epilepsy with febrile
seizures plus (GEFS+) had a K289M mutation in the 2 subunit of the
GABAA receptor. This residue is located in the
short extracellular loop between transmembrane domains TM2 and TM3, a
region that has been implicated in the gating of ligand-gated ion
channels (Campos-Caro et al., 1996 ; Lynch et al., 1997 ).
Electrophysiological recordings from oocytes expressing
1 2 2(K289M) GABAA receptors revealed
smaller amplitude currents relative to wild-type receptor current amplitudes.
Although the pathophysiology of epilepsy is complex, and heritable
epilepsies represent a small fraction of all patients with epilepsy, mutations such as those discovered by Baulac et al. (2001)
and Wallace et al. (2001) may shed light on the importance of specific
aspects of GABAA receptor function in the
maintenance of central synaptic inhibition. Because 2
subunit-containing receptors are primarily localized to synapses and
inhibitory synaptic transmission occurs in the millisecond time domain,
it is necessary to consider the possible impact of these mutations on
channel properties relevant to the time scale of synaptic transmission. Thus, we used an ultrafast perfusion technique to ensure resolution of
rapid kinetic properties such as activation, desensitization, and
deactivation. Finally, we studied both mutations at the single-channel level to determine the basis of our macroscopic observations.
 |
MATERIALS AND METHODS |
Expression of recombinant GABAA
receptors. The cDNAs encoding rat 1, 3, and 2L,
GABAA receptor subunit subtypes were individually subcloned into the plasmid expression vector pCMVNeo. Initially we
performed experiments with these rat subunits because human subunits
were unavailable to us. The rat 2L subunit mature peptide differs
from the reported human 2L subunit sequence (Pritchett et al., 1989 ;
accession NM 000816) by two residues (of 428): the rat sequence
contains a T at position 81 (M in human) and a T at position 142 (S in
human). After our observation of robust diazepam enhancement of the
2L(R43Q) mutation (which contrasted Wallace et al., 2001 ) (Fig.
1), we obtained the cDNAs encoding human
1, 3, and 2S subunits in the expression vector pCIneo, provided by Dr. Erwin Sigel (University of Bern, Switzerland), to
verify that species differences in subunit sequence did not account for
our results. Interestingly, the human 2S subunit contained the rat
amino acid sequence at these two sites, resulting in 100% amino acid
sequence identity. This 2 sequence has also been reported by the
NCBI Annotation Project (accession XM 003986.2). Nevertheless, we
mutated the two residues to match the original published human 2
sequence to evaluate diazepam sensitivity of the 2L(R43Q) mutation
in both contexts (Fig. 1D). Twenty-four bases of the
cytoplasmic loop were introduced into the human 2S subunit to
generate the human 2L splice form used in these experiments. Point
mutants were generated using the QuikChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA). All subunits and mutations were
confirmed by sequencing. Oligonucleotide primers were synthesized by
the University of Michigan DNA synthesis core facility (Ann Arbor, MI).
Human embryonic kidney cells (HEK293T; a gift from P. Connely, COR
Therapeutics, San Francisco, CA) were maintained in DMEM,
supplemented with 10% fetal bovine serum, at 37°C in 5%
CO2 and 95% air. For expression of both rat and
human isoforms, cells were transfected with 2-4 µg of each subunit
plasmid along with 1-2 µg of pHOOK (Invitrogen, Carlsbad, CA) (in a
ratio of 1:1:1:0.5) for immunomagnetic bead separation (Greenfield et
al., 1997 ), using a modified calcium phosphate coprecipitation
technique, as previously described (Angelotti et al., 1993 ). The next
day, cells were replated on collagen-treated culture dishes, and
recordings were made at room temperature 18-30 hr later.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 1.
Sensitivity to GABA and diazepam.
A, The EC50 for GABA was determined by
whole-cell responses to increasing GABA concentration, normalized to
the peak current amplitude in each cell. Cells were voltage clamped at
-10 to -50 mV, and data were obtained from three cells
for each mutation. The dotted line is the
concentration-response of wild-type 1 3 2L GABAA
receptors (Bianchi et al., 2001 ). B, Diazepam
sensitivity was determined by coapplication of 1 µM
diazepam with 2 µM GABA (~EC20) to
whole cells expressing 1 3 2L (top),
1 3 2L(K289M), or 1 3 2L(R43Q) GABAA
receptors. C, Diazepam enhancement is shown as the
percentage of control responses (averagepeak current before and after diazepam coapplication).
Neither mutation significantly affected modulation of GABA-evoked
currents by diazepam. D, Representative currents are
shown for two human 1 3 2L(R43Q) GABAA receptor
isoforms. The left pair of traces indicated the response
of receptors containing a 2L subunit with amino acid sequence
corresponding to the original published 2L sequence, whereas the
right pair of traces indicated the response of receptors
containing a 2L subunit with amino acid sequence corresponding to
that of the rat 2L subunit (see Materials and Methods). For both
pairs of traces, the left current was evoked with 10 µM
GABA (solid bar), and the right current was evoked with
coapplied 1 µM diazepam (hatched bar) in
the same cell. Similar results were obtained in five cells.
|
|
Electrophysiology. Patch-clamp recordings were performed on
membrane patches excised from transfected fibroblasts bathed in an
external solution consisting of (in mM): NaCl
142; KCl 8; MgCl2 6; CaCl2
1; HEPES 10; glucose 10, pH 7.4, 325 mOsm. Electrodes were pulled from
thick-walled borosilicate glass (World Precision Instruments,
Pittsburgh, PA) with a Flaming Brown electrode puller (Sutter
Instruments, San Rafael, CA), fire-polished to resistances of 4-12
M when filled with an internal solution consisting of (in
mM): KCl 153; MgCl2 1;
MgATP 2; HEPES 10; EGTA 5, pH 7.3, 300 mOsm. Electrodes used for
single-channel recording were coated with polystyrene Q-dope (GC
Electronics). This combination of internal and external solutions
produced a chloride equilibrium potential of ~0 mV. All outside-out
patches used for macroscopic kinetic experiments were voltage-clamped
at 50 mV using an Axon Instruments (Foster City, CA) 200A amplifier.
All single-channel recordings were performed at 75 mV. For
macroscopic experiments, drugs were applied (via gravity) to whole
cells and excised outside-out patches using a rapid perfusion system
consisting of pulled multibarrel square glass connected to a Warner
Instrument Corp. (Hamden, CT) Perfusion Fast-Step. The glass was pulled
to a final size of ~200 µm. The solution exchange time was
determined after each excised patch recording by stepping a dilute
external solution across the open electrode tip to measure a liquid
junction current. The 10-90% rise times for solution exchange were
consistently <400 µsec. For whole-cell experiments, lower resistance
thin-walled borosilicate electrodes were used (0.8-1.5 M ), and
whole cells were generally voltage clamped at 20 mV, although more
hyperpolarized potentials were used to increase the chloride ion
driving force when small currents were observed. Exchange time around
whole cells was probably slower than the open tip rise times. For
single-channel recordings, GABA (1 mM) was
applied directly to the bath solution and was present for at least 2 min before recordings were started. The sampling intervals of currents
used for figure traces were reduced by decimation (averaging of
adjacent points) and/or additional filtering for display purposes only.
Analysis. Macroscopic currents were low-pass filtered at
2-5 kHz, digitized at 10 kHz, and analyzed using the pClamp8 software suite (Axon Instruments). The desensitization and deactivation time
courses of GABAA receptor currents were fit using
the Levenberg-Marquardt least squares method with one or two component
exponential functions of the form
ane(-t/ n),
where n is the best number of exponential components,
a is the relative amplitude of the component, t
is time, and is the time constant. Three component fits were not
considered for the 400 msec duration pulses used in this study. A
second component was accepted only if a significant improvement of the
fit occurred, as determined by an F-test performed automatically by
Clampfit 8.1 analysis software on the sum of squared residuals. In
every patch, the second exponential function improved the
desensitization fit. Note that faster phases of apparent
desensitization could not be resolved if they occurred with time
constants below the solution exchange time of our system (~400
µsec) or if they were faster than the current rise time (< 1 msec).
For comparison of deactivation time courses a weighted summation of the
fast and slow decay components was used, in which the time constants of the fast and slow phases were weighted by their relative amplitudes. For paired pulse inhibition analysis, the relative amplitude of the
second peak was measured for comparison with the first peak of each
sweep pair. When the second pulse occurred before the current of the
first pulse had relaxed completely (i.e., for brief interpulse
intervals), the current remaining from the first pulse was subtracted
from the absolute peak of the second amplitude, thus generating a
relative amplitude measurement.
Single-channel data were digitized at 20 kHz, filtered at 2 kHz via the
internal Axon 200A amplifier filter, and stored on VHS videotape for
off-line analysis. Most patches used for single-channel analysis
contained more than one channel, based on the presence of overlapped
openings. Stretches of single-channel activity that contained few or no
overlapped openings were analyzed using the 50% threshold detection
method of Fetchan 6.0 (pClamp 8.1). Overlapped openings and bursts were
not included in the analysis. Events with durations <150 µsec
(~1.5 times the estimated system dead time) were shown in the
histograms but not considered in the fitting routine. Logarithmic
binning was used as previously described (Haas and Macdonald, 1999 ),
and fitted with a maximum likelihood routine by the Interval5 software
(Dr. Barry Pallotta, University of North Carolina). The number of
exponential functions required to fit the distributions was incremented
until additional exponentials failed to significantly improve the fit,
as determined automatically by the software (analysis of residuals).
Mean open times were calculated from the open duration fitted
parameters of a histogram containing the combined results from several patches.
Numerical data were expressed as mean ± SEM. Statistical
significance, using Student's unpaired t test (with a
Welch's correction for unequal variances where appropriate) was taken
as p < 0.05.
 |
RESULTS |
The biophysical properties of the rat 1 3 2L
GABAA receptor isoform have been extensively
studied (Fisher and Macdonald, 1997 ; Haas and Macdonald, 1999 ). The
well characterized transient and steady-state kinetics offered an
appropriate context for evaluation of the K289M and R43Q mutations in
the 2 subunit recently linked to human epilepsy. Initial
characterization was performed at the whole-cell level. The
EC50 for GABA was determined, using relatively rapid perfusion (see Materials and Methods), by applying increasing concentrations of GABA to whole cells voltage clamped at 10 to 50
mV. As shown in Figure 1A, neither mutation changed
the GABA EC50, consistent with Baulac et al.
(2001) and Wallace et al. (2001) . Modulation of
GABAA receptors by the benzodiazepine diazepam depends on the presence of a subunit and the appropriate subunit subtype (Sigel and Buhr, 1997 ). We tested the effects of both mutations on benzodiazepine sensitivity, as indicated by the diazepam modulation of currents elicited by a low concentration of GABA (~EC20). Diazepam (1 µM) significantly and reversibly enhanced 1 3 2L(K289M) and 1 3 2L(R43Q)
GABAA receptor currents, and the extent of
enhancement was not different from that observed for wild-type
1 3 2L GABAA receptor currents (Fig.
1B,C). We also examined the diazepam sensitivity of
two human isoforms of the 2L(R43Q) subunit (see Materials and
Methods) expressed with human 1 and human 3 subunits. Diazepam
significantly potentiated these human isoforms, despite the R43Q
mutation (Fig. 1D). Although we used the 3
subunit, and the previous studies used the 2 subunit, this should
not affect our results because diazepam sensitivity is known to depend
on the and subunits, but not the subunit subtype. This was
consistent with the results of Baulac et al. (2001) , who found diazepam
enhancement of receptors containing the 2(K289M) mutation, but
contrasted with the results of Wallace et al. (2001) , in which
1 2 2(R43Q) GABAA receptors were shown to
be insensitive to diazepam (1 µM) when
expressed in Xenopus oocytes. In that study, the possibility
of endogenous benzodiazepine ligand or ligands had been raised as a
result of that finding.
One major limitation of standard "whole-cell" electrophysiology is
the failure to accurately resolve rapid kinetic processes because of
the technical difficulty in perfusing whole cells sufficiently fast to
avoid "blurring" rapid channel responses to agonist. To overcome
this limitation and allow investigation of the kinetic behavior of
GABAA receptors containing the reported
mutations, we used the concentration jump technique applied to outside
out patches excised from transfected human fibroblasts (Fig.
2A). This permitted
analysis of receptor properties most relevant to the time scale of
synaptic currents, including activation, desensitization, and
deactivation. We have previously shown that 400 msec pulses of GABA (1 mM) elicit rapidly activating currents from
1 3 2L receptors that desensitize with two phases and deactivate
slowly (Haas and Macdonald, 1999 ; Bianchi et al., 2001 ). This duration of application is appropriate for resolving the fast phase of desensitization ( ~10 msec) thought to play a critical role in shaping GABAA receptor current deactivation and
by extension, IPSC duration (Jones and Westbrook, 1995 ;
Dominguez-Perrot et al., 1997 ; Haas and Macdonald, 1999 ). The
pattern of current desensitization during the 400 msec GABA application
was well described by the sum of two exponential functions in every
patch (see Materials and Methods). The rates (Fig.
2B1,C1) and relative contributions (Fig.
2B2,C2) of the fast and slow phases of macroscopic
desensitization were unaffected by the mutations. Neither mutation
significantly altered the macroscopic activation rate, as indicated by
the 10-90% current rise time (Fig. 2D). The mean
peak amplitude of 1 3 2L(R43Q) currents was significantly
smaller (p < 0.01) than either 1 3 2L or
1 3 2L(K289M) currents (which were not different from each other) (Fig. 2E). Also, the 1 3 2L(K289M)
currents deactivated significantly faster (p < 0.001) than either 1 3 2L or 1 3 2L(R43Q) currents, which
were not different from each other (Fig. 2F).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 2.
Macroscopic kinetic properties. A,
Representative current traces obtained from wild-type or mutated
receptors during 400 msec jumps into 1 mM GABA. Time scale
of top trace applies to all three traces.
B1-C2, Neither the fast
(B1) nor the slow (C1) time constant of
desensitization, nor their relative contributions (B2,
C2) were significantly altered by the mutations.
D, Current activation rate, as indicated by the 10-90%
rise time of the current, was not significantly altered by the
mutations. E, Peak current amplitudes were significantly
smaller for 1 3 2L(R43Q) GABAA receptors.
*p < 0.01. F, Current deactivation
after removal of GABA was significantly faster for 1 3 2L(K289M)
GABAA receptors. *p < 0.001. Data were
obtained from 8-13 patches.
|
|
To more closely approximate the conditions of synaptic currents, we
applied GABA (1 mM) to patches for short durations (2-5 msec) (Fig. 3A1-A3). The
traces (dark lines) are shown at the same vertical scale to
demonstrate the dramatic effect of the R43Q mutation on peak current.
The gray trace in Figure 3A3 is a 10-fold vertical expansion
shown for comparison of the deactivation time course. Such applications
may reasonably replicate the time course of IPSCs (Jones and Westbrook,
1995 ; Haas and Macdonald, 1999 ), and provide information about
GABAA receptor current deactivation under
nonequilibrium conditions. Deactivation currents relaxed with a
biphasic time course for all three isoforms. 1 3 2L(K289M) currents deactivated significantly faster than 1 3 2L currents (p < 0.05), whereas the deactivation rate was
unaffected by the 2L(R43Q) mutation (Fig. 3B). For
comparison purposes, only the weighted deactivation rates are shown in
Figure 3B.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 3.
Deactivation after brief GABA pulses.
A, Representative currents illustrate deactivation rates
of 1 3 2L (A1), 1 3 2L(K289M)
(A2), and 1 3 2L(R43Q) (A3)
GABAA receptors in response to brief (<5 msec)
pulses of GABA (1 mM). Scale bars apply to all three
solid traces. The solid trace in
A3 is expanded 10-fold (gray
trace) for comparison of deactivation current time course.
B, Weighted time constants of deactivation (see
Materials and Methods) are shown for wild-type and mutated channels.
Deactivation was significantly faster for 1 3 2L(K289M)
GABAA receptors (hatched bar).
*p < 0.05. 1 3 2L (R43Q) GABAA
receptor deactivation (solid bar) was not different than
that of wild-type receptors (gray bar). Data were
obtained from 9-13 patches for each isoform.
|
|
One consequence of GABAA receptor entry into
relatively long-lasting desensitized states (even after brief exposure
to GABA) is that subsequent exposure to GABA will elicit smaller
current responses. This phenomenon is known as paired pulse inhibition, in which the smaller amplitude of the second response of paired GABA
applications reflects a fraction of receptors that cannot be activated
because they remain desensitized. As the interpulse interval is
increased, channels recover from desensitization, and progressively
less depression is observed in the peak current of the second GABA
pulse. We investigated paired pulse inhibition using paired brief
applications of 1 mM GABA separated by varying interpulse
intervals (30-1000 msec). Prominent paired pulse inhibition was
observed for 1 3 2L and 1 3 2L(R43Q)
GABAA receptors (Fig. 4A, top and
bottom panels), and the degree of inhibition for each interval was not different between these two isoforms. Although paired
pulse inhibition was observed for 1 3 2L(K289M)
GABAA receptor channels (Fig. 4A,
middle trace), the degree of inhibition was smaller for each
interpulse interval (p < 0.05) (Fig.
4B). In other words, more current activation occurred
(as indicated by greater current amplitude) in the second pulse of each
pair compared with the same interpulse intervals for 1 3 2L
GABAA receptors. Single exponential fitting of
the mean relative amplitude data revealed that 1 3 2L and
1 3 2L(R43Q) receptors recovered with similar time constants of
130 and 170 msec, respectively, whereas 1 3 2L(K289M) receptors
recovered with a significantly faster time constant of 57 msec
(p < 0.05).

View larger version (21K):
[in this window]
[in a new window]
|
Figure 4.
Paired pulse inhibition. Pairs of 5 msec GABA (1 mM) pulses were delivered to outside-out patches at
interpulse intervals of 30, 100, 300, and 1000 msec. A,
Representative currents from wild-type and mutated GABAA
receptors. B, Summary plot showing the relative
amplitude of the second pulse of each pair, for each four interpulse
intervals. Less inhibition was observed for 1 3 2L(K289M)
GABAA receptors for each interpulse interval.
|
|
Finally, we investigated the single-channel properties of
1 3 2L(K289M) and 1 3 2L(R43Q)
GABAA receptors to determine whether changes in
gating or conductance might explain the faster deactivation and smaller
amplitude currents, respectively. Single-channel currents were recorded
from outside-out patches during steady-state application of GABA (1 mM). Neither mutation appeared to change the single-channel conductance, because the majority of openings for each isoform was ~2
pA at 75 mV (Fig. 5A), as
previously reported for 1 x 2 GABAA
receptors (Angelotti et al., 1993 ; Fisher and Macdonald, 1997 ; Haas and
Macdonald, 1999 ). The R43Q mutation did not appear to substantially
change the pattern of burst-like openings (three fitted open states;
data not shown). The mean open duration was slightly but significantly
shorter than wild-type (1.3 msec compared with 2.0 msec) (see Materials
and Methods). Interestingly, the open durations of 1 3 2L(K289M)
GABAA receptor channels were substantially
shorter in duration than both 1 3 2L and 1 3 2L(R43Q) mean open times, although they still also tended to occur in bursts. The mean open duration was only 0.5 msec, fourfold shorter than that
observed for 1 3 2L. The open duration histogram is shown in
Figure 5D to illustrate the predominance of the first, brief duration open state, and the almost complete absence of the longer, third open state characteristic of 1 3 2L single-channel
currents.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 5.
Single-channel analysis. Single-channel records
obtained in patches held at 75 mV in the presence of 1 mM
GABA from 1 3 2L (A), 1 3 2L(R43Q)
(B), and 1 3 2L(K289M)
(C) GABAA receptors. A portion of the
top trace in each pair (indicated by the open
bar) is expanded below that trace. Calibration bars apply to
all three panels. Openings are downward. Similar results were observed
from three 1 3 2L, five 1 3 2L(R43Q), and seven
1 3 2L(K289M) patches. D, Open duration histogram
for 1 3 2L(K289M) single channels. The distribution was best
described by the sum of three exponential functions, with each
exponential fit shown as a smooth curve. Although three functions were
required, the relative contribution of the shortest open state
(leftmost curve) was highest, indicating that most
openings were brief in duration. The time constants were 0.33, 1.17, and 4.54 msec with relative areas 0.81, 0.17, and 0.02, respectively.
Data were pooled from seven 1 3 2L(K289M) patches.
|
|
 |
DISCUSSION |
The goal of this study was to determine the functional
consequences of two recently described mutations of the
GABAA receptor 2 subunit linked to human
epilepsy. Specifically, the concentration jump technique was used to
explore the rapid kinetic properties thought to be most relevant for
the time scale of synaptic transmission. Our results differ from the
initial reports of functional deficits associated with these mutations.
First, we found unaltered diazepam potentiation for
GABAA receptors containing the 2L(R43Q)
mutated subunit. Wallace et al. (2001) suggested the possible existence of endogenous benzodiazepines based on the diazepam insensitivity conferred by this mutation in their in vitro assay. Second,
we found no difference in the amplitudes of currents obtained from GABAA receptors containing the 2L(K289M)
mutated subunit, in contrast with the systematically smaller currents
observed in oocytes by Baulac et al. (2001) . We did, however, observe
functional consequences of these mutations that would be consistent
with decreased neuronal inhibition: faster deactivation rates for
1 3 2L(K289M) GABAA receptors (which
predicts shorter duration IPSCs) and smaller currents for
1 3 2L(R43Q) GABAA receptors (which
predicts smaller amplitude IPSCs).
The basis for the discrepancies between our results and those of
Wallace et al. (2001) and Baulac et al. (2001) remain unclear. The
functional differences may be associated with the expression system
(oocytes versus a human cell line). For example,
GABAA receptor assembly in mammalian cells has
been shown to be less promiscuous than in Xenopus oocytes
(Sieghart, 1995 ). Additionally, both previous studies used 10-fold
overexpression of the 2 subunit to drive assembly of ternary
receptors; it is not known how such overexpression might alter receptor
assembly or function. We achieved consistent expression of ternary
GABAA receptor channels with equimolar cDNA
ratios, based on various functional criteria such as modulator
pharmacology, single-channel conductance, and rapid kinetic properties
(Angelotti et al., 1993 ; Fisher and Macdonald, 1997 ; Haas and
Macdonald, 1999 ). Also, we tested two human 2L(R43Q) subunits (see
Materials and Methods) expressed with human 1 and human 3
subunits and observed robust diazepam enhancement, indicating that
species differences in amino acid sequence could not account for the
contrasting benzodiazepine sensitivity (Wallace et al., 2001 ).
GABAA receptor deactivation is the major
determinant of IPSC duration and is influenced by transitions among
open, closed, and desensitized states, as well as GABA unbinding steps.
Although GABA unbinding is the terminating event for current
deactivation, open, pre-open and desensitized states detain GABA on the
receptor, thereby prolonging the IPSC time course (Jones and Westbrook, 1995 ; Chang and Weiss, 1999 ; Bianchi and Macdonald, 2001a ). Thus, there
are several mechanisms by which deactivation might be accelerated. Because there was no change in apparent GABA
EC50, it is unlikely that decreased microscopic
affinity alone could account for the faster deactivation of
1 3 2L(K289M) currents. Macroscopic desensitization was
unaltered by the mutation, arguing against changes in desensitized states that contribute to the prolonged deactivation rate.
Single-channel gating efficacy (opening and closing rates) can also
affect deactivation (Bianchi and Macdonald, 2001b ). We observed
significantly decreased mean open times for 1 3 2L(K289M)
GABAA receptor single channels. This finding is
consistent with the accelerated deactivation, because channels would
spend less time in the open state for any given opening before
eventually unbinding GABA. Channels that were open at the end of the
GABA pulse would close faster than wild-type channels, and although
"late" re-openings (that normally underlie slow deactivation) would
still occur, they would contribute less current to the deactivation
time course, resulting in an overall accelerated current relaxation.
This phenotype of fast deactivation despite unaltered desensitization
time course is similar to that observed for receptors containing
mutations in TM1 of the 2L subunit (Bianchi et al., 2001 ). In that
study, we concluded that desensitization and deactivation had been
"uncoupled" by the mutation, and we raised two possible explanations. It might be that TM1 was a critical site for structural interactions between conformations of TM2 (related to the presumed channel gate) and GABA binding sites in the N terminus. An alternative is that a decrease in gating efficacy would accelerate deactivation independent of desensitization. The K-M mutation appears to
significantly decrease the mean open time of single-channel events,
consistent with the latter possibility. Interestingly, we have found
shorter mean open times (our unpublished data) with the TM1
mutation that uncoupled desensitization and deactivation. These
findings suggest that gating and desensitization can be modified
independently and that gating efficacy is also a critical determinant
of deactivation rate and thus IPSC time course. Consistent with these
suggestions, we recently presented evidence that a mutation that
increased gating efficacy prolonged deactivation without altering
desensitized states (Bianchi and Macdonald, 2001b ).
Interestingly, although shorter duration of individual synaptic events
would be a predicted outcome of the K289M mutation, less paired pulse
inhibition would suggest a decrease in the temporal constraints
normally imposed on repetitive firing at GABAergic synapses. Whereas
the shorter deactivation predicts less inhibition of individual events,
the potential for increased inhibition allowed by less effective paired
pulse inhibition might partially compensate for the decreased
inhibition of individual events predicted by the faster deactivation.
How these two predictions may interact in vivo is not yet
known, but may provide insight into the mechanism of epileptogenesis.
It remains unclear whether the decreased paired pulse inhibition is a
result of faster recovery from desensitization or an indirect
consequence of the decreased gating efficacy.
Our data are consistent with previous studies that suggested the
importance of the TM2-TM3 loop in the gating of ligand-gated ion
channels (Campos-Caro et al., 1996 ; Lynch et al., 1997 ; Sigel et al.,
1999 ). In some cases, mutations in this domain result in clinical
phenotypes. For example, slow channel myasthenic syndrome can be caused
by TM2-TM3 loop mutation in nicotinic acetylcholine receptors (Gomez
et al., 1997 ). Also, glycine receptor mutations in this loop
region have been shown to result in hereditary hyperekplexia (for
review, see Lewis and Schofield, 1999 ).
In any transfection paradigm, there is inherent variability in protein
expression of exogenous cDNAs among individual cells. However,
interfering with some aspect of expression or assembly can result in a
systematic decrease in current amplitude. Note that current amplitude,
even under conditions of rapid agonist application, may be affected by
kinetic properties of the channels as well as the level of surface
expression (for example, see Haas and Macdonald, 1999 ). However,
1 3 2L(R43Q) GABAA receptor currents did
not differ significantly in activation, desensitization, or deactivation rates and did not have decreased single-channel
conductance or significantly altered gating kinetics. Although the mean
open time was shorter compared with wild-type, this difference could not quantitatively account for the smaller currents. Therefore these
observations suggest that receptor expression or assembly has been
compromised by the mutation. It is known that N-terminal sequences are
important for assembly of GABAA receptors
(Klausberger et al., 2000 ). Although the sequence around R43 was not
specifically identified as important for intersubunit contacts, the
absolute conservation of the R43 residue across subunits and species is more consistent with a role in assembly (which is required of all
subunits) than with benzodiazepine modulation (which is highly subunit-
and subtype-selective). Indeed, several human diseases have been linked
to mutations in conserved arginines (among other residues) that result
in altered protein folding and subsequent degradation (Bross et al.,
1999 ). Also, a recent study showed that mutation of a conserved basic
arg-lys sequence in the intracellular domain of nicotinic acetylcholine
receptors altered intracellular trafficking mechanisms (Keller et al.,
2001 ). Further studies are necessary to determine whether this mutation
alters protein folding or processing.
How these mutations actually contribute to complex seizure disorders
remains unclear. The decreased inhibitory drive caused by faster
current deactivation (K289M) or smaller current amplitudes (R43Q) are
both consistent with imbalances of neuronal activity that would favor a
hyperexcitable state. It should be noted, however, that native synaptic
GABAA receptors likely contain a single 2 subunit (Chang et al., 1996 ) resulting in a mixture of wild-type and
mutant receptors in patients with either mutation. Although the portion
of synaptic receptors containing the K289M mutation would accelerate
IPSC time courses, alterations in assembly related to the R43Q mutant
subunits might simply result in decreased peak currents. The extent of
this effect would depend on whether compensatory increases in
expression of the wild-type subunit occurred, which is not known.
Further experiments involving expression of a mixture of wild-type and
mutated subunits would clarify these potentially intermediate
functional consequences. Also, this study did not address possible
functional consequences that might depend on interaction of mutated
2 subunits and other or subunits or manifestations of these
mutations that depend on a neuronal milieu. Knock-in animal models may
further elucidate the molecular mechanisms through which these
mutations contribute to seizure disorders in vivo.
 |
FOOTNOTES |
Received Dec. 17, 2001; revised April 12, 2002; accepted April 17, 2002.
This work was supported National Institutes of Health Grant R01-NS33300
(R.L.M.) and National Institute on Drug Abuse training Fellowship
T32-DA07281-03 (M.T.B.). We thank Gallia Levy for valuable discussions.
Correspondence should be addressed to Dr. Robert L. Macdonald,
Department of Neurology, Vanderbilt University, 2100 Pierce Avenue,
Nashville, TN 37212. E-mail: Robert.Macdonald{at}mcmail.vanderbilt.edu.
 |
REFERENCES |
-
Angelotti TP,
Uhler MD,
Macdonald RL
(1993)
Assembly of GABAA receptor subunits: analysis of transient single-cell expression utilizing a fluorescent substrate/marker gene technique.
J Neurosci
13:1418-1428[Abstract].
-
Bianchi MT,
Macdonald RL
(2001a)
Agonist trapping by GABAA receptor channels.
J Neurosci
21:9083-9091[Abstract/Free Full Text].
-
Bianchi MT,
Macdonald RL
(2001b)
Mutation of the 9' leucine in the GABAA receptor
2L subunit produces an apparent decrease in desensitization by stabilizing open states without altering desensitized states.
Neuropharmacology
41:737-744[Web of Science][Medline]. -
Bianchi MT,
Haas KF,
Macdonald RL
(2001)
Structural determinants of fast desensitization and desensitization-deactivation coupling in GABAA receptors.
J Neurosci
21:1127-1136[Abstract/Free Full Text].
-
Baulac S,
Huberfeld G,
Gourfinkel-An I,
Mitropoulou G,
Beranger A,
Prud'homee J-F,
Baulac M,
Brice A,
Bruzzone R,
LeGuern E
(2001)
First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the
2-subunit gene.
Nat Genet
28:46-48[Web of Science][Medline]. -
Bross P,
Corydon TJ,
Andresen BS,
Jorgensen MM,
Bolund L,
Gregersen N
(1999)
Protein misfolding and degradation in genetic diseases.
Hum Mutat
14:186-198[Web of Science][Medline].
-
Campos-Caro A,
Sala S,
Ballesta JJ,
Vincente-Agullo F,
Criado M,
Sala F
(1996)
A single residue in the M2-M3 loop is a major determinant of coupling between binding and gating in neuronal nicotinic receptors.
Proc Natl Acad Sci USA
93:6118-6123[Abstract/Free Full Text].
-
Chang Y,
Weiss DS
(1999)
Channel opening locks agonist onto the GABAC receptor.
Nat Neurosci
2:219-225[Web of Science][Medline].
-
Chang Y,
Wang R,
Barot S,
Weiss DS
(1996)
Stoichiometry of a recombinant GABAA receptor.
J Neurosci
16:5415-5424[Abstract/Free Full Text].
-
Dominguez-Perrot C,
Feltz P,
Poulter MO
(1997)
Recombinant GABAA receptor desensitization: the role of the gamma2 subunit and its physiological significance.
J Physiol (Lond)
497:145-159[Abstract/Free Full Text].
-
Fisher JL,
Macdonald RL
(1997)
Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells.
J Physiol (Lond)
505:283-297[Abstract/Free Full Text].
-
Gomez CM,
Maselli R,
Gundeck JE,
Chao M,
Day JW,
Tamamizu S,
Lasalde JA,
McNamee M,
Wollman RL
(1997)
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.
J Neurosci
17:4170-4179[Abstract/Free Full Text].
-
Greenfield Jr LJ,
Sun F,
Neelands TR,
Burgard EC,
Donnelly JL,
Macdonald RL
(1997)
Expression of functional GABAA receptors in transfected L929 cells isolated by immunomagnetic bead separation.
Neuropharmacology
36:63-73[Web of Science][Medline].
-
Haas KF,
Macdonald RL
(1999)
GABAA receptor subunit
2 and subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts.
J Physiol (Lond)
514(1):27-45[Abstract/Free Full Text]. -
Jones MV,
Westbrook GL
(1995)
Desensitized states prolong GABAA channel responses to brief agonist pulses.
Neuron
15:181-191[Web of Science][Medline].
-
Keller SH,
Lindstrom J,
Ellisman M,
Taylor P
(2001)
Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-subunit.
J Biol Chem
276:18384-18391[Abstract/Free Full Text].
-
Klausberger T,
Fuchs K,
Mayer B,
Ehya N,
Sieghart W
(2000)
GABAA receptor assembly: identification and structure of
2 sequences forming the intersubunit contacts with 1 and 3 subunits.
J Biol Chem
275:8921-8928[Abstract/Free Full Text]. -
Lewis TM,
Schofield PR
(1999)
Structure-function relationships of the human glycine receptor: insights from hyperekplexia mutations.
Ann NY Acad Sci
868:681-684[Web of Science][Medline].
-
Lynch JW,
Rajendra S,
Pierce KD,
Handford CA,
Barry PH,
Schofield PR
(1997)
Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel.
EMBO J
16:110-120[Web of Science][Medline].
-
Macdonald RL,
Olsen RW
(1994)
GABAA receptor channels.
Annu Rev Neurosci
17:569-602[Web of Science][Medline].
-
McKernan RM,
Whiting PJ
(1996)
Which GABAA-receptor subtypes really occur in the brain?
Trends Neurosci
19:139-143[Web of Science][Medline].
-
Pritchett DB,
Sontheimer H,
Shivers BD,
Ymer S,
Kettenmann H,
Schofield PR,
Seeburg PH
(1989)
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.
Nature
338:582-585[Medline].
-
Sieghart W
(1995)
Structure and pharmacology of
-aminobutyric acidA receptor subtypes.
Pharmacol Rev
47:181-234[Web of Science][Medline]. -
Sigel E,
Buhr A
(1997)
The benzodiazepine binding site of GABAA receptors.
Trends Pharmacol Sci
18:425-429[Medline].
-
Sigel E,
Buhr A,
Baur R
(1999)
Role of the conserved lysine residue in the middle of the predicted extracellular loop between M2 and M3 in the GABA(A) receptor.
J Neurochem
73:1758-1764[Web of Science][Medline].
-
Wallace RH,
Marini C,
Petrou S,
Harkin L,
Bowser DN,
Panchal RG,
Williams DA,
Sutherland GR,
Mulley JC,
Scheffer IE,
Berkovic SF
(2001)
Mutant GABAA receptor
2 subunit in childhood absence epilepsy and febrile seizures.
Nat Genet
28:49-52[Web of Science][Medline].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22135321-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. M. O'Shea, C. A. Williams, and A. Jenkins
Inverse Effects on Gating and Modulation Caused by a Mutation in the M2-M3 Linker of the GABAA Receptor {gamma} Subunit
Mol. Pharmacol.,
September 1, 2009;
76(3):
641 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Q. Kang, W. Shen, and R. L. Macdonald
The GABRG2 Mutation, Q351X, Associated with Generalized Epilepsy with Febrile Seizures Plus, Has Both Loss of Function and Dominant-Negative Suppression
J. Neurosci.,
March 4, 2009;
29(9):
2845 - 2856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fedi, S. F. Berkovic, R. A. L. Macdonell, J. M. Curatolo, C. Marini, and D. C. Reutens
Intracortical Hyperexcitability in Humans with a GABAA Receptor Mutation
Cereb Cortex,
March 1, 2008;
18(3):
664 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Eugene, C. Depienne, S. Baulac, M. Baulac, J. M. Fritschy, E. Le Guern, R. Miles, and J. C. Poncer
GABAA Receptor {gamma}2 Subunit Mutations Linked to Human Epileptic Syndromes Differentially Affect Phasic and Tonic Inhibition
J. Neurosci.,
December 19, 2007;
27(51):
14108 - 14116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. O. Tan, C. A. Reid, F. N. Single, P. J. Davies, C. Chiu, S. Murphy, A. L. Clarke, L. Dibbens, H. Krestel, J. C. Mulley, et al.
Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy
PNAS,
October 30, 2007;
104(44):
17536 - 17541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gallagher, L. Ding, A. Maheshwari, and R. L. Macdonald
The GABAA receptor {alpha}1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation
PNAS,
August 7, 2007;
104(32):
12999 - 13004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-B. Liu, J. Coble, G. van Luijtelaar, and E. G. Jones
Reticular nucleus-specific changes in {alpha}3 subunit protein at GABA synapses in genetically epilepsy-prone rats
PNAS,
July 24, 2007;
104(30):
12512 - 12517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Frugier, F. Coussen, M.-F. Giraud, M.-F. Odessa, M. B. Emerit, E. Boue-Grabot, and M. Garret
A {gamma}2(R43Q) Mutation, Linked to Epilepsy in Humans, Alters GABAA Receptor Assembly and Modifies Subunit Composition on the Cell Surface
J. Biol. Chem.,
February 9, 2007;
282(6):
3819 - 3828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bessaih, L. Bourgeais, C. I. Badiu, D. A. Carter, T. I. Toth, D. Ruano, B. Lambolez, V. Crunelli, and N. Leresche
Nucleus-Specific Abnormalities of GABAergic Synaptic Transmission in a Genetic Model of Absence Seizures
J Neurophysiol,
December 1, 2006;
96(6):
3074 - 3081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Audenaert, E. Schwartz, K. G. Claeys, L. Claes, L. Deprez, A. Suls, T. Van Dyck, L. Lagae, C. Van Broeckhoven, R. L. Macdonald, et al.
A novel GABRG2 mutation associated with febrile seizures.
Neurology,
August 22, 2006;
67(4):
687 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Hales, T. Z. Deeb, H. Tang, K. A. Bollan, D. P. King, S. J. Johnson, and C. N. Connolly
An Asymmetric Contribution to {gamma}-Aminobutyric Type A Receptor Function of a Conserved Lysine within TM2-3 of {alpha}1, beta2, and {gamma}2 Subunits
J. Biol. Chem.,
June 23, 2006;
281(25):
17034 - 17043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Q. Kang, W. Shen, and R. L. Macdonald
Why Does Fever Trigger Febrile Seizures? GABAA Receptor {gamma}2 Subunit Mutations Associated with Idiopathic Generalized Epilepsies Have Temperature-Dependent Trafficking Deficiencies
J. Neurosci.,
March 1, 2006;
26(9):
2590 - 2597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Feng, J.-Q. Kang, L. Song, L. Dibbens, J. Mulley, and R. L. Macdonald
{delta} Subunit Susceptibility Variants E177A and R220H Associated with Complex Epilepsy Alter Channel Gating and Surface Expression of {alpha}4beta2{delta} GABAA Receptors
J. Neurosci.,
February 1, 2006;
26(5):
1499 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gallagher, W. Shen, L. Song, and R. L. Macdonald
Endoplasmic Reticulum Retention and Associated Degradation of a GABAA Receptor Epilepsy Mutation That Inserts an Aspartate in the M3 Transmembrane Segment of the {alpha}1 Subunit
J. Biol. Chem.,
November 11, 2005;
280(45):
37995 - 38004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jin, J. R. Huguenard, and D. A. Prince
Impaired Cl- Extrusion in Layer V Pyramidal Neurons of Chronically Injured Epileptogenic Neocortex
J Neurophysiol,
April 1, 2005;
93(4):
2117 - 2126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sancar and C. Czajkowski
A GABAA Receptor Mutation Linked to Human Epilepsy ({gamma}2R43Q) Impairs Cell Surface Expression of {alpha}{beta}{gamma} Receptors
J. Biol. Chem.,
November 5, 2004;
279(45):
47034 - 47039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kang and R. L. Macdonald
The GABAA Receptor {gamma}2 Subunit R43Q Mutation Linked to Childhood Absence Epilepsy and Febrile Seizures Causes Retention of {alpha}1{beta}2{gamma}2S Receptors in the Endoplasmic Reticulum
J. Neurosci.,
October 6, 2004;
24(40):
8672 - 8677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Feng and R. L. Macdonald
Proton Modulation of {alpha}1{beta}3{delta} GABAA Receptor Channel Gating and Desensitization
J Neurophysiol,
September 1, 2004;
92(3):
1577 - 1585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. George Jr
Molecular Basis of Inherited Epilepsy
Arch Neurol,
April 1, 2004;
61(4):
473 - 478.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Hinkle and R. L. Macdonald
{beta} Subunit Phosphorylation Selectively Increases Fast Desensitization and Prolongs Deactivation of {alpha}1{beta}1{gamma}2L and {alpha}1{beta}3{gamma}2L GABAA Receptor Currents
J. Neurosci.,
December 17, 2003;
23(37):
11698 - 11710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lossin, T. H. Rhodes, R. R. Desai, C. G. Vanoye, D. Wang, S. Carniciu, O. Devinsky, and A. L. George Jr
Epilepsy-Associated Dysfunction in the Voltage-Gated Neuronal Sodium Channel SCN1A
J. Neurosci.,
December 10, 2003;
23(36):
11289 - 11295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Joseph, B. Niggemann, K. S. Zaenker, and F. Entschladen
The Neurotransmitter {gamma}-Aminobutyric Acid Is an Inhibitory Regulator for the Migration of SW 480 Colon Carcinoma Cells
Cancer Res.,
November 15, 2002;
62(22):
6467 - 6469.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|